Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19
Gaetano Alfano(University of Modena and Reggio Emilia), Giovanni Guaraldi(University of Modena and Reggio Emilia), Francesco Fontana(Ospedale di Monfalcone), Monica Frisina(University of Modena and Reggio Emilia), Erica Franceschini(University of Modena and Reggio Emilia), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Roberto Tonelli(University of Modena and Reggio Emilia), Niccolò Morisi(Azienda Ospedaliero-Universitaria di Modena), Gabriele Donati(University of Modena and Reggio Emilia), Annachiara Ferrari(University of Modena and Reggio Emilia)
Cited by 8
Related Papers
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404